EDGAR Filing Documents for 0001367920-17-000007

Form 8-K - Current report:

SEC Accession No. 0001367920-17-000007

Filing Date

2017-03-06

Accepted

2017-03-06 07:22:22

Documents

Period of Report

2017-03-06

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	q416-8xkshell.htm	8-K	31779
2	EXHIBIT 99.1	a2016exhibit991.htm	EX-99.1	16938
3	EXHIBIT 99.2	q416pressrelease.htm	EX-99.2	112593
4		concertimage8ka05.jpg	GRAPHIC	15744
	Complete submission text file	0001367920-17-000007.txt		184401

Mailing Address 99 HAYDEN AVENUE SUITE 500 LEXINGTON MA 02421

Business Address 99 HAYDEN AVENUE SUITE 500 LEXINGTON MA 02421 781-860-0045

CONCERT PHARMACEUTICALS, INC. (Filer) CIK: 0001367920 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36310 | Film No.: 17666474
SIC: 2834 Pharmaceutical Preparations